On August 19, 2020, Cellivery Therapeutics, Inc. (KOSDAQ:A268600) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,680 KRW | -29.91% | -.--% | -.--% |
2023 | Cellivery Therapeutics, Inc.(KOSDAQ:A268600) dropped from S&P Global BMI Index | CI |
2021 | Cellivery Therapeutics, Inc. acquired Ajin Clean Co., Ltd. from SVAJ Holdings for KRW 14.2 billion. | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,29,800 KRW | -0.61% | -2.99% | 2.54B | ||
5,130 KRW | +0.59% | -6.90% | 188M | ||
1st Jan change | Capi. | |
---|---|---|
-.--% | 178M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- A268600 Stock
- News Cellivery Therapeutics, Inc.
- Cellivery Therapeutics, Inc. announced that it has received KRW 43.9988081 billion in funding from a group of investors